Advair Archives -

Shares in Hikma have rallied as it resumed the launch of its generic Advair Diskus in the US,

Hikma shares rally after US launch of Advair generic resumes

https://pharmaphorum.com/news/hikma-shares-rally-after-us-launch-of-advair-generic-resumes/

UK-listed Hikma Pharma has filed a response to the FDA that it hopes will clear the way for

Chasing Mylan, Hikma tries again with rejected generic Advair in US

https://pharmaphorum.com/news/chasing-mylan-hikma-tries-again-with-rejected-generic-advair-in-us/

GlaxoSmithKline is expecting flat earnings this year, having earlier forecast a decline, as rising sales of new drugs

Shingrix and Trelegy shield GSK from Advair fallout

https://pharmaphorum.com/news/gsk-advair-shingles-vaccine-trelegy/

GSK’s first quarter sales beat estimates, helped along by shingles vaccine Shingrix and partly offsetting the effect of

Shingles vaccine boosts GSK as generic Advair bites

https://pharmaphorum.com/news/shingles-vaccine-boosts-gsk-as-generic-advair-bites/

GlaxoSmithKline looks set to have another year without US generic competition to its respiratory blockbuster Advair, after the

Advair reprieve gives GSK breathing space

https://pharmaphorum.com/news/advair-reprieve-gives-gsk-breathing-space/

Luke Miels to start role after GSK and AZ end contract row.

GSK’s new pharma chief Miels to join in September

https://pharmaphorum.com/news/gsks-new-pharma-chief-join-september/

Advair